FundComb
Confirmed Preliminary Control Closed (unverified) Transaction verified Consumerprobiotic manufacturingprobiotics

UAS Laboratories LLC acquired by Chr. Hansen Holding A/S

Chr. Hansen Holding A/S acquired UAS Laboratories LLC, a US probiotics brand, on Jul 28, 2020.

Preliminary: The announcement date, completion date, deal status, transaction value, value basis, EV/revenue, metric basis and value notes are not yet independently verified.

Transaction summary

Target
UAS Laboratories LLC
Announced
2020-06-09(unverified)
Geography
United States
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-07-13
Latest update
2026-10-29

Value and multiples

100% enterprise value

USD 530M

Unverified

100% enterprise value | USD

Basis: FundComb estimate

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

6.2x

Unverified

Period not stated

Basis: FundComb estimate

EV / EBITDA

-

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • No calculation performed. The revenue multiple is taken directly from the spreadsheet paste; revenue base and metric period are not provided.

Source summary

UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S - PR Newswire

Confirmed
Open via Google News

Continue your research

Related transaction comps

Explore more comps →
Same buyer / investor

Jennewein Biotechnologie GmbH acquired by Chr. Hansen Holding A/S

2020-09-22 · Confirmed

View transaction → probiotic manufacturing

Bucklebury acquired by Haleon

2022-09-01 · Confirmed

View transaction → probiotics

Adare Biome acquired by dsm-firmenich AG

2023-04-19 · Confirmed

View transaction → probiotics

PrecisionBiotics Group Limited acquired by Novozymes

2020-06-25 · Estimated

View transaction →